Victory Capital Management Inc Arvinas, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 46,520 shares of ARVN stock, worth $887,601. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,520

Previous 53,912 13.71%

Holding current value

$887,601

Previous $1.44 Million 20.21%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$23.66 - $32.73 $174,894 - $241,940	-7,392 Reduced 13.71%	46,520 $1.15 Million
Q2 2024 Aug 05, 2024	BUY	$24.46 - $40.4 $365,041 - $602,929	14,924 Added 38.28%	53,912 $1.44 Million
Q1 2024 May 03, 2024	BUY	$36.38 - $52.31 $1.19 Million - $1.7 Million	32,582 Added 508.62%	38,988 $1.61 Million
Q4 2023 Feb 05, 2024	BUY	$14.19 - $42.33 $90,901 - $271,165	6,406 New	6,406 $263,000
Q3 2022 Nov 02, 2022	SELL	$41.87 - $57.99 $3,391 - $4,697	-81 Reduced 0.84%	9,573 $426,000
Q2 2022 Aug 01, 2022	BUY	$36.01 - $74.24 $46,668 - $96,215	1,296 Added 15.51%	9,654 $406,000
Q1 2022 May 04, 2022	SELL	$60.27 - $81.57 $221,914 - $300,340	-3,682 Reduced 30.58%	8,358 $459,000
Q4 2021 Feb 07, 2022	SELL	$65.85 - $96.21 $71,974 - $105,157	-1,093 Reduced 8.32%	12,040 $989,000
Q3 2021 Nov 02, 2021	BUY	$73.2 - $107.87 $188,416 - $277,657	2,574 Added 24.38%	13,133 $1.08 Million
Q2 2021 Aug 03, 2021	BUY	$60.45 - $84.26 $263,985 - $367,963	4,367 Added 70.53%	10,559 $813,000
Q1 2021 May 04, 2021	BUY	$58.19 - $91.37 $17,224 - $27,045	296 Added 5.02%	6,192 $409,000
Q4 2020 Feb 01, 2021	SELL	$20.19 - $84.93 $59,398 - $249,864	-2,942 Reduced 33.29%	5,896 $501,000
Q3 2020 Nov 09, 2020	SELL	$22.99 - $36.34 $128,123 - $202,522	-5,573 Reduced 38.67%	8,838 $209,000
Q2 2020 Aug 07, 2020	BUY	$29.88 - $56.74 $145,366 - $276,040	4,865 Added 50.96%	14,411 $483,000
Q1 2020 May 04, 2020	BUY	$33.0 - $54.5 $178,200 - $294,300	5,400 Added 130.25%	9,546 $385,000
Q4 2019 Feb 06, 2020	SELL	$15.39 - $44.38 $2,093 - $6,035	-136 Reduced 3.18%	4,146 $170,000
Q4 2019 Feb 04, 2020	BUY	$15.39 - $44.38 $38,136 - $109,973	2,478 Added 137.36%	4,282 $208,000
Q3 2019 Nov 12, 2019	BUY	$21.55 - $27.61 $38,876 - $49,808	1,804 New	1,804 $39,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Arvinas, Inc. Transaction History